ESH Video

#ESHCML2022 LATE BREAKING ABSTRACTS: DEADLINE APPROACHING

July 22, 2022

24th ANNUAL JOHN GOLDMAN CONFERENCE ON
CHRONIC MYELOID LEUKEMIA:
BIOLOGY AND THERAPY


October 21-23, 2022
Mandelieu-La Napoule, France
#ESHCML2022

Co-organizers: Ravi Bhatia, Tim Brümmendorf, Mhairi Copland, Michael Deininger, Olivier Hantschel, François-Xavier Mahon, Danilo Perrotti, Jerry Radich, Delphine Réa

Advisory Committee: Jane Apperley, Susan Branford, Carlo Gambacorti-Passerini, François Guilhot, Rüdiger Hehlmann, Pierre Laneuville, Giuseppe Saglio, Charles Schiffer, Simona Soverini, Peter Valent, Rick Van Etten

 

LATE BREAKING ABSTRACT
DEADLINE COMING UP!
DO NOT MISS THE OPPORTUNITY




 

JOIN US ON OCTOBER 21, 2022
 in Mandelieu-La Napoule, France!
We are looking forward to welcoming you face-to-face!




ABOUT THE JOHN GOLDMAN CONFERENCE:

Strong basic and clinical science:
Speakers at this meeting will present new, often unpublished data related to the (1) Biology of CML including the origin of BCR-ABL1, signal transduction, basis of disease progression, action of tyrosine kinase inhibitors and mechanisms underlying resistance to TKI, and (2) aspects of treatment including prediction and definition of responses, drugs used in combination, modern diagnostics and molecular monitoring, targeting residual stem cells, approaches to cure and treatment free remission.

The program will include:
     - Special Lectures
     - Keynote Lectures
     - Oral Communications selected from Submitted Abstracts
     - Workshops for Non-Clinical Scientists
     - Mentored Poster Walks: Clinical and Biology
     - Michele Baccarani Special Symposium (topic to be announced)
     - The John Goldman Prize Ceremony and Lecture
     - The Janet Rowley Prize Ceremony and Lecture
     - The iCMLf Prize Ceremony and Lecture
     - The ESH John Goldman International Research Award ceremony
and scientific presentation

Stay tuned, the preliminary program will be available soon...

MORE INFORMATION

 

 

With the support of*:


Diamond Conference Partner

*******



*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.